Login to Your Account

Acceleron Pharma Prices Upbeat IPO

By Peter Winter
BioWorld Insight Edtor

Thursday, September 19, 2013
The sky is getting crowded as biotech companies on the initial public offering (IPO) runway continue to take off with increasing regularity. The latest to get airborne is Cambridge, Mass.-based Acceleron Pharma Inc., which priced its IPO Thursday. The upscaled offering generated almost $84 million from the sale of 5.58 million shares of common stock at $15 per share.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription